Global 3D Printed Drugs Market exhibited a value of USD 214.3 million Global 3D Printed Drugs Market exhibited a value o | Page 2

development by the top pharmaceutical companies like GlaxoSmithKline across
have led to the burgeoning market growth of 3D printed drug market.
Download Sample Brochure : https://tinyurl.com/y8jranmk
Fused deposition modeling segment is expected to dominate the global 3D
printed drugs market during the forecast period. In 2017, more than half of the
market share was held by the fused deposition modeling technique. However,
the inkjet printing technique type is expected to witness the fastest growth rate
in the coming years because of growing adoption among healthcare
professionals and patients due to extreme advancement in technology.
Increasing research & development coupled with technological advancement in
the pharmaceutical drug are likely to spur the growth of the global 3D printed
drugs market in near future.
“To tackle the deadly diseases pharmaceutical companies along with the 3D
printing technology players are investing a lot in research and development of
the 3D printed drugs. For instance, recently HP partnered with the Centers for
Disease Control (CDC) for developing 3D printed drugs for the US’s deadly
disease “Superbugs”. Every year around 2.0 million people in the US get directly
infected with these superbugs and about 23.0 thousand people die due to the
improper medical treatment. It is foreseen that personalized drugs will propel
the growth of the 3D printed drugs market by 2025 “
—-GMI Research
In 2017, North America held the largest share in the market on the back of
increased adoption of technology, large volume epilepsy of patients and
innovation in 3D drug technology and procedures. In addition, there has been a
rise in the incidence of epilepsy disease. Europe has been amongst the growing
regions for healthcare 3D printed drugs market and is predicted to grow at a
moderate rate during the forecast period.
Buy Report Now @ https://tinyurl.com/y8jranmk